SCHEMBL7423458

SCHEMBL7423458

CC(=O)C1Cc2ccccc2N(C(=O)OCc2ccccc2)C1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
SMN1; SMN2 Q16637 4/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
NOTUM Q6P988 1/20 0.46
TMEM97 Q5BJF2 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
HTR2C P28335 1/20 0.44
CACNA1G O43497 1/20 0.44
CACNA1H O95180 1/20 0.44
CACNA1I Q9P0X4 1/20 0.44
P2RX4 Q99571 2/20 0.44
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 1/20 0.43
P2RX1 P51575 1/20 0.43
P2RX3 P56373 1/20 0.43
CTRB1 P17538 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423459 1.00 NPC1 (0.60) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8560198 0.90 NPC1 (0.62) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL7424161 0.90 NPC1 (0.62) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8566008 0.90 NPC1 (0.62) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8562502 0.88 NPC1 (0.57) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8562508 0.88 NPC1 (0.57) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8562505 0.88 NPC1 (0.57) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8568888 0.87 NPC1 (0.56) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8569404 0.87 NPC1 (0.56) NPC1RAB9AL3MBTL1SMN1; SMN2GAA
SCHEMBL8569399 0.87 NPC1 (0.56) NPC1RAB9AL3MBTL1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 WO disclosed